Rockwell Medical Technologies (NASDAQ: RMTI) reported Q4 EPS of ($0.12), $0.14 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $14.1 million versus the consensus estimate of $19.98 million.

For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.